Literature DB >> 9544980

Immunologic thrombocytopenic purpura as presenting symptom of hepatitis C infection.

F Bauduer1, F Marty, M Larrouy, L Ducout.   

Abstract

We report on 3 female patients with immunologic thrombocytopenic purpura (ITP) for whom diagnostic procedures evidenced a chronic Hepatitis C virus (HCV) infection. In 2 cases, a transfusion performed more than 10 years ago represented the probable way of contamination. One patient received a course of steroids, which normalized the platelet counts. Another one has been treated with repeated IV immunoglobulins, which induced partial responses of variable duration. HCV is responsible for many autoimmune manifestations and a search for this virus seems warranted for exploring patients with ITP.

Entities:  

Mesh:

Year:  1998        PMID: 9544980     DOI: 10.1002/(sici)1096-8652(199804)57:4<338::aid-ajh12>3.0.co;2-4

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection.

Authors:  Elizabeth Y Chiao; Eric A Engels; Jennifer R Kramer; Kenneth Pietz; Louise Henderson; Thomas P Giordano; Ola Landgren
Journal:  Arch Intern Med       Date:  2009-02-23

2.  Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.

Authors:  Kristen M Marks; Robin M A Clarke; James B Bussel; Andrew H Talal; Marshall J Glesby
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

Review 3.  Overwhelming postsplenectomy infection syndrome in adults - a clinically preventable disease.

Authors:  Takehiro Okabayashi; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

4.  Prevalence of thrombocytopenia among Chinese adult antiretroviral-naïve HIV-positive patients.

Authors:  Hong-Wei Fan; Fu-Ping Guo; Yi-Jia Li; Ning Li; Tai-Sheng Li
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.